Company news

Amphastar Pharmaceuticals, Inc. news

Latest news releases, newest first. Pick a year for every news release, call and deck from that year.

View company

Amphastar Pharmaceuticals to Release First Quarter Earnings and Hold Conference Call on May 8, 2024

April 29, 2024

Amphastar Pharmaceuticals to Present at the 23rd Annual Needham Virtual Healthcare Conference

March 31, 2024

Amphastar Pharmaceuticals to Present at the Barclays 26th Annual Global Healthcare Conference

March 5, 2024

Amphastar Pharmaceuticals Reports Financial Results for the Three Months and Full-Year Ended December 31, 2023

February 27, 2024

Amphastar Pharmaceuticals to Release Fourth Quarter Earnings and Hold Conference Call on February 28, 2024

February 19, 2024

Amphastar Pharmaceuticals to Present at the 42nd Annual J.P. Morgan Healthcare Conference

January 1, 2024

Amphastar Pharmaceuticals to Present at the Piper Sandler 35th Annual Healthcare Conference

November 19, 2023

Amphastar Pharmaceuticals Reports Financial Results for the Three Months Ended September 30, 2023

November 7, 2023

Amphastar Pharmaceuticals to Release Third Quarter Earnings and Hold Conference Call on November 8, 2023

October 31, 2023

Amphastar Pharmaceuticals Announces Pricing of Offering of $300.0 Million of Convertible Senior Notes

September 12, 2023

Amphastar Pharmaceuticals Announces Proposed Private Offering of $300.0 Million of Convertible Senior Notes

September 10, 2023

Amphastar Pharmaceuticals to Present at the Wells Fargo Healthcare Conference

August 30, 2023

Amphastar Pharmaceuticals Reports Financial Results for the Three Months Ended June 30, 2023

August 7, 2023

Amphastar Pharmaceuticals to Release Second Quarter Earnings and Hold Conference Call on August 8, 2023

August 1, 2023

Amphastar Pharmaceuticals Completes Acquisition of BAQSIMI from Lilly

June 29, 2023

Amphastar Pharmaceuticals to Present at the Jefferies Healthcare Conference

May 30, 2023

Amphastar Pharmaceuticals Reports Financial Results for the Three Months Ended March 31, 2023

May 8, 2023

Amphastar Pharmaceuticals to Release First Quarter Earnings and Hold Conference Call on May 9, 2023

May 2, 2023

Lilly to Divest BAQSIMI to Amphastar

April 23, 2023

Amphastar Pharmaceuticals Business Update and Hold Conference Call on April 24th, 2023

April 23, 2023

Amphastar Pharmaceuticals to Present at the 22nd Annual Needham Virtual Healthcare Conference

April 11, 2023

Amphastar Pharmaceuticals Receives FDA Approval for Naloxone Hydrochloride Nasal Spray 4mg

March 7, 2023

Amphastar Pharmaceuticals Reports Financial Results for the Three Months and Full-Year Ended December 31, 2022

February 27, 2023

Amphastar Pharmaceuticals to Release Fourth Quarter Earnings and Hold Conference Call on February 28, 2023

February 21, 2023

Amphastar Pharmaceuticals to Present at the Piper Sandler 34th Annual Healthcare Conference

November 21, 2022

Amphastar Pharmaceuticals to Present at the 2022 Jefferies London Healthcare Conference

November 9, 2022

Amphastar Pharmaceuticals Reports Financial Results for the Three Months Ended September 30, 2022

November 6, 2022

Amphastar Pharmaceuticals to Release Third Quarter Earnings and Hold Conference Call on November 7, 2022

October 27, 2022

Amphastar Pharmaceuticals to Present at the Wells Fargo 2022 Healthcare Conference

September 1, 2022

Amphastar Pharmaceuticals Receives FDA Approval for Epinephrine Pre-Filled Syringes

August 15, 2022

Amphastar Pharmaceuticals Reports Financial Results for the Three Months Ended June 30, 2022

August 7, 2022

Amphastar Pharmaceuticals to Release Second Quarter Earnings and Hold Conference Call on August 8, 2022

July 31, 2022

Amphastar Receives FDA Approval for Vasopressin

July 18, 2022

Amphastar Receives FDA Approval for Regadenoson

May 23, 2022

Amphastar Pharmaceuticals Reports Financial Results for the Three Months Ended March 31, 2022

May 8, 2022

Amphastar Pharmaceuticals to Release First Quarter Earnings and Hold Conference Call on May 9, 2022

May 1, 2022

Amphastar Receives FDA Approval for Ganirelix Acetate Injection

April 7, 2022

Amphastar Pharmaceuticals to Present at the 21st Annual Needham Virtual Healthcare Conference

April 5, 2022

Amphastar Pharmaceuticals Reports Financial Results for the Three Months and Full-Year Ended December 31, 2021

March 9, 2022

Amphastar Pharmaceuticals to Release Fourth Quarter Earnings and Hold Conference Call on March 10th, 2022

March 2, 2022

Amphastar Receives FDA Tentative Approval for Vasopressin

December 28, 2021

Amphastar Pharmaceuticals to Present at the Piper Sandler 33rd Annual Virtual Healthcare Conference

November 21, 2021

Amphastar Pharmaceuticals Reports Financial Results for the Three Months Ended September 30, 2021

November 7, 2021

Amphastar Pharmaceuticals to Release Third Quarter Earnings and Hold Conference Call on November 8th, 2021

October 27, 2021

Amphastar Pharmaceuticals to Present at the Wells Fargo 2021 Virtual Healthcare Conference

September 1, 2021

Amphastar Pharmaceuticals Reports Financial Results for the Three Months Ended June 30, 2021

August 8, 2021

Amphastar Pharmaceuticals to Release Second Quarter Earnings and Hold Conference Call on August 9th, 2021

July 28, 2021

Amphastar Pharmaceuticals to Present at the Raymond James Human Health Innovation Conference

June 14, 2021

Amphastar Pharmaceuticals to Present at the Jefferies Virtual Healthcare Conference

May 26, 2021

Amphastar Announces Buyback of 26% of the Equity in its ANP Subsidiary and Spin-off its Hanxin Subsidiary

May 6, 2021

← Newer news releases · Older news releases →

Calls

The 5 newest of 17 calls. Every call is listed under its year.

Decks

The 5 newest of 30 decks. Every deck is listed under its year.